The Food and Drug Administration issued an “early alert” concerning FreeStyle Libre 3 and FreeStyle Libre Plus sensors used by people who have diabetes. The agency said Abbott Diabetes Care has sent a ...
Patients are being warned to stop using some glucose monitors made by Abbott Diabetes Care after the company found malfunctioning sensors may be linked to hundreds of adverse events and several deaths ...
Abbott has initiated a voluntary medical device correction for a number of FreeStyle Libre 3 sensors distributed in the United States during the first half of May 2024. The FreeStyle Libre 3 system ...
Continuous glucose monitoring (CGM) tracks glucose levels every 1 to 5 minutes, helping people with diabetes understand how food, sleep, and exercise affect their blood sugar without frequent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results